标题
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
作者
关键词
Inflammation, Atherosclerosis, Lipoprotein(a), Cardiovascular diseases
出版物
PHARMACOLOGICAL RESEARCH
Volume 169, Issue -, Pages 105689
出版商
Elsevier BV
发表日期
2021-05-24
DOI
10.1016/j.phrs.2021.105689
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
- (2021) Daniel I Swerdlow et al. CARDIOVASCULAR RESEARCH
- Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology
- (2021) Michael M. Page et al. CURRENT OPINION IN CARDIOLOGY
- IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression
- (2021) Emmanuel Tharmarajah et al. JOURNAL OF INFECTION
- Emerging RNA Therapeutics to Lower Blood Levels of Lp(a)
- (2021) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2021) Paul M Ridker et al. LANCET
- Potential of Lipoprotein(a)-Lowering Strategies in Treating Coronary Artery Disease
- (2020) Baris Gencer et al. DRUGS
- Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the “Montignoso Study”
- (2020) Alice Sereni et al. Internal and Emergency Medicine
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The dedicated “Lp(a) clinic”: A concept whose time has arrived?
- (2020) Sotirios Tsimikas et al. ATHEROSCLEROSIS
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
- (2020) Johan G. Schnitzler et al. CIRCULATION RESEARCH
- Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
- (2020) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?
- (2020) Barbara Cybulska et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
- (2020) Patrick M. Moriarty et al. Current Atherosclerosis Reports
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
- (2020) Ron C Hoogeveen et al. CLINICAL CHEMISTRY
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paraoxonase 1 (PON1) Q192R and L55M polymorphisms, lipid profile, lipid peroxidation and lipoprotein-a levels in Turkish patients with pregnancy-related disorders
- (2019) Birsen Aydemir et al. GYNECOLOGICAL ENDOCRINOLOGY
- Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis
- (2019) Brian T. Steffen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Current Role of Lipoprotein Apheresis
- (2019) Gilbert Thompson et al. Current Atherosclerosis Reports
- Statin therapy increases lipoprotein(a) levels
- (2019) Sotirios Tsimikas et al. EUROPEAN HEART JOURNAL
- ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance
- (2019) Bastian Ramms et al. JOURNAL OF LIPID RESEARCH
- Methotrexate for Cardiovascular Risk Reduction: The Right Choice?
- (2019) Željko Reiner et al. ANGIOLOGY
- Heritability of Apolipoprotein(a) Traits in Two-Generational African-American and Caucasian Families
- (2019) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk
- (2019) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?
- (2019) Henry N. Ginsberg et al. JOURNAL OF CLINICAL INVESTIGATION
- ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters
- (2019) Richard E Morton et al. JOURNAL OF LIPID RESEARCH
- Potent reduction of plasma lipoprotein(a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis
- (2019) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- 2417Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab
- (2019) P M Ridker et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- ApoC3: an ‘alarmin’ triggering sterile inflammation
- (2019) Tao Gong et al. NATURE IMMUNOLOGY
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction
- (2018) Thor Ueland et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab
- (2018) Paul M Ridker et al. Journal of Clinical Lipidology
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
- (2018) Xuchu Que et al. NATURE
- Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities Study
- (2018) Anum Saeed et al. ATHEROSCLEROSIS
- High lipoprotein(a) and high risk of mortality
- (2018) Anne Langsted et al. EUROPEAN HEART JOURNAL
- Persistent arterial wall inflammation in patients with elevated lipoprotein(a) despite strong low-density lipoprotein cholesterol reduction by proprotein convertase subtilisin/kexin type 9 antibody treatment
- (2018) Lotte C A Stiekema et al. EUROPEAN HEART JOURNAL
- Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects
- (2018) Renu Nandakumar et al. JOURNAL OF LIPID RESEARCH
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proteomic Analysis of Liver from Human Lipoprotein(a) Transgenic Mice Shows an Oxidative Stress and Lipid Export Response
- (2018) Euan J. Rodger et al. Biomed Research International
- A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis
- (2017) Masako Ueda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
- (2017) Carmen García-Gómez et al. Journal of Clinical Lipidology
- Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III
- (2017) M. Ghosh Laskar et al. JOURNAL OF INTERNAL MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study
- (2017) Seoyoung C. Kim et al. Arthritis & Rheumatology
- Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
- (2017) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective
- (2016) Gissette Reyes-Soffer et al. CIRCULATION
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoprotein (a): a historical appraisal
- (2016) Karam M. Kostner et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): Coming of Age at Last
- (2016) Joseph L. Witztum et al. JOURNAL OF LIPID RESEARCH
- Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
- (2016) Robert W. Mahley JOURNAL OF MOLECULAR MEDICINE-JMM
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2016) Amirhosssein Sahebkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
- (2015) Cem Gabay et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
- (2015) Corey A. Scipione et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
- (2015) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
- (2015) Nike Müller et al. JOURNAL OF LIPID RESEARCH
- Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
- (2015) K. Yamamoto et al. JOURNAL OF RHEUMATOLOGY
- Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins
- (2014) Anne von Zychlinski et al. Journal of Proteomics
- Pro-Inflammatory Interleukin-1 Genotypes Potentiate the Risk of Coronary Artery Disease and Cardiovascular Events Mediated by Oxidized Phospholipids and Lipoprotein(a)
- (2014) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis
- (2013) Aart C. Strang et al. ATHEROSCLEROSIS
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
- (2013) Gregor Leibundgut et al. JOURNAL OF LIPID RESEARCH
- The current status of lipoprotein (a) in pregnancy: A literature review
- (2012) Angela E. Fanshawe et al. Journal of Cardiology
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
- (2011) Adam Taleb et al. Biomarkers in Medicine
- Farnesoid X receptor represses hepatic human APOA gene expression
- (2011) Indumathi Chennamsetty et al. JOURNAL OF CLINICAL INVESTIGATION
- Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans
- (2011) Heiner K. Berthold et al. PLoS One
- Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
- (2011) C. Christoffersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay
- (2010) Vincent Mooser et al. CLINICAL GENETICS
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases
- (2010) Olaf Schultz et al. PLoS One
- Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors
- (2009) Sotirios Tsimikas et al. CIRCULATION
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
- (2009) Shin-ya Kawashiri et al. RHEUMATOLOGY INTERNATIONAL
- The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity
- (2008) Sotirios Tsimikas et al. CURRENT OPINION IN LIPIDOLOGY
- A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
- (2008) Claes Bergmark et al. JOURNAL OF LIPID RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started